Meals MATTER: A Trial of Medically Tailored Meals 2 Weeks vs. 4 Weeks Post Hospital Discharge

NCT ID: NCT04351880

Last Updated: 2022-02-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

650 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-04-16

Study Completion Date

2021-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine if medically tailored meals provided for either 2 weeks or 4 weeks (1 meal per day) to a Kaiser Permanente Colorado (KPCO) member after hospital discharge will improve their health. Medically tailored meals (MTM) are meals that are approved by a dietitian and shown to help people with certain health conditions.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The purpose of this study is to determine if medically tailored meals provided for either 2 weeks or 4 weeks (1 meal per day) to a Kaiser Permanente Colorado (KPCO) member after hospital discharge will improve their health. Medically tailored meals (MTM) are meals that are approved by a dietitian and shown to help people with certain health conditions.

The Investigators propose a research study with four Specific Aims:

Specific Aim 1: To determine if MTM provided post hospitalization for 4 weeks to patients with one or more of seven chronic health conditions will decrease depression/anxiety measured by the Hospital Anxiety and Depression Scale (HADS) at 60 days in comparison to meals provided for 2 weeks to members discharged from two hospitals.

Hypothesis 1: Patients receiving meals for 4 weeks will have a clinically significant increase in their HADS score at 60 days compared to those receiving meals for 2 weeks.

Specific Aim 2: To determine if MTM provided for 4 weeks to patients with one or more of seven chronic health conditions post hospitalization will improve general well-being and functional status measured by Katz's Activities of Daily Living (ADL).

Hypothesis 2: Patients receiving meals for 4 weeks will have a clinically significant increase in their sense of well-being and ADLs at 60 days compared to those receiving meals for 2 weeks.

Specific Aim 3: To determine if MTM provided for 4 weeks to patients with one or more of seven chronic health conditions post hospitalization will decrease a composite outcome of rehospitalizations and emergency department (ED) visits at 60 days in comparison to: a) meals provided for 2 weeks to members discharged from two hospitals; and b) a concurrent prospective control group not receiving meals at two other KPCO-contracted hospitals.

Hypothesis 3: Patients receiving meals for 4 weeks will have a decreased composite rate of rehospitalizations and ED visits at 60 days compared to those receiving meals for 2 weeks or the non-randomized control group.

Specific Aim 4: To determine the feasibility, acceptability and scalability of the Meals Matter Program to KP members, their households, and hospital leadership and staff.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heart Failure Copd Liver Failure Diabetes Mellitus Cancer End Stage Renal Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

This is a randomized trial to compare two approaches to meal delivery. Group 1 will receive meal delivery for 2 weeks (1 meal per day for a total of 14 days) and Group 2 will receive meal delivery for 4 weeks (1 meal per day for a total of 28 days). A concurrent propensity matched control group which will not receive an intervention will also be used.
Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Meals - 2 weeks

Receive meal delivery for 2 weeks (1 meal per day for a total of 14 days). The medically tailored meal ordered for each participant will depend on their medical conditions.

Group Type ACTIVE_COMPARATOR

Medically Tailored Meals

Intervention Type OTHER

Compare 2 and 4 weeks of meal delivery

Meals - 4 weeks

Receive meal delivery for 4 weeks (1 meal per day for a total of 28 days). The medically tailored meal ordered for each participant will depend on their medical conditions.

Group Type ACTIVE_COMPARATOR

Medically Tailored Meals

Intervention Type OTHER

Compare 2 and 4 weeks of meal delivery

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Medically Tailored Meals

Compare 2 and 4 weeks of meal delivery

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 18 or older, with no upper age limit
* Hospitalized at Saint Joseph Hospital or Good Samaritan Medical Center with the anticipation that they will be discharged home
* Member of a KP health plan
* Have one or more of the following conditions:

* Heart failure
* Cancer
* End-stage renal disease (ESRD)/chronic renal disease
* Chronic obstructive pulmonary disease (COPD)
* Diabetes Mellitus
* Chronic liver disease/cirrhosis

Exclusion Criteria

* Patient discharged to a nursing home, an assisted living facility, or another setting where meals are institutionally provided
* Patient has a health condition which is incompatible with the diet choices offered by Project Angel Heart (PAH - food service vendor)
* Patient refuses the type of meal best for their medical condition
* Patient has dementia
* Patient is pregnant or hospitalized peri-partum
* Patient is an active participant in a PAH program or another meal program
* Patient is unable to speak English or Spanish
* PAH unable to deliver meals due to patient not being in PAH service area
* Patient was discharged from the hospital within 24 hours of admission
* Patient whose household member has enrolled in the Meals MATTER study
* Patient discharged to hospice care
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kaiser Permanente

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Rebecca S Boxer, MD, MS

Role: PRINCIPAL_INVESTIGATOR

KP Institute for Health Research

John Steiner, MD, MPH

Role: STUDY_DIRECTOR

KP Institute for Health Research

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

St Joseph's Hospital

Denver, Colorado, United States

Site Status

Good Samaritan Medical Center

Lafayette, Colorado, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IRB-1556587

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Food Insecurity, Social Determinants of Health
NCT06784310 ACTIVE_NOT_RECRUITING NA
Medifast 5 & 1 Plan
NCT01211301 COMPLETED NA
Meal Replacement Study
NCT02355041 WITHDRAWN PHASE3
Food is Medicine: Pilot Study
NCT06797453 COMPLETED NA